Depixus

Depixus is an emerging player in the genomics and life-science tools sector, commercializing its proprietary MAGNA One platform for high-throughput magnetic force spectroscopy. The technology allows researchers to visualize and measure the forces of individual molecular interactions—such as protein-protein or drug-RNA binding—in real time and at scale, generating rich, dynamic data. As a private, pre-revenue company, it is focused on instrument placement in academic and core labs to drive adoption and demonstrate utility across various biological research applications. Its leadership team combines scientific, medical, and commercial expertise, having raised significant capital to fund its growth.

MAGNA One platform utilizing magnetic force spectroscopy (MFS) for real-time, parallel analysis of thousands of single-molecule interactions (e.g., protein-protein, drug-RNA).

Depixus competes with established ensemble techniques (e.g., SPR, ITC) and other single-molecule methods like optical tweezers and atomic force microscopy, which are often lower throughput or more complex. Its key differentiator is the combination of single-molecule resolution, high parallelism, and real-time dynamics measurement.